These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21768880)

  • 1. Bone effects of cancer therapies: pros and cons.
    Silbermann R; Roodman GD
    Curr Opin Support Palliat Care; 2011 Sep; 5(3):251-7. PubMed ID: 21768880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
    Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
    Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of aromatase inhibitors on bone metabolism.
    Folkestad L; Bjarnason NH; Bjerregaard JK; Brixen K
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):3-10. PubMed ID: 19152547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib mesylate does not increase bone volume in vivo.
    O'Sullivan S; Naot D; Callon KE; Watson M; Gamble GD; Ladefoged M; Karsdal MA; Browett P; Cornish J; Grey A
    Calcif Tissue Int; 2011 Jan; 88(1):16-22. PubMed ID: 20978751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
    Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
    Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
    J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucocorticoids on the skeleton.
    Canalis E; Pereira RC; Delany AM
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1341-5. PubMed ID: 12510988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone- and chemotherapy-induced bone loss in breast cancer.
    Coleman RE
    Oncology (Williston Park); 2004 May; 18(5 Suppl 3):16-20. PubMed ID: 15202583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease.
    Heider U; Hofbauer LC; Zavrski I; Kaiser M; Jakob C; Sezer O
    Biochem Biophys Res Commun; 2005 Dec; 338(2):687-93. PubMed ID: 16216218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength.
    Wezeman FH; Emanuele MA; Emanuele NV; Moskal SF; Woods M; Suri M; Steiner J; LaPaglia N
    Alcohol Clin Exp Res; 1999 Sep; 23(9):1534-42. PubMed ID: 10512321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tetracyclines on bones: an ambiguous question needs to be clarified.
    Cheng W; Yue Y; Fan W; Hu Y; Wang X; Pan X; Zhou X; Qin L; Zhang P
    Pharmazie; 2012 May; 67(5):457-9. PubMed ID: 22764582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Src inhibitors and aromatase inhibitors: a novel strategy for overcoming endocrine resistance and bone loss.
    Hiscox S; Barrett-Lee P; Borley AC; Nicholson RI
    Eur J Cancer; 2010 Aug; 46(12):2187-95. PubMed ID: 20471823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.
    Boissy P; Andersen TL; Lund T; Kupisiewicz K; Plesner T; Delaissé JM
    Leuk Res; 2008 Nov; 32(11):1661-8. PubMed ID: 18394701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New agents in development for breast cancer.
    Gao XP; Liu F
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):68-74. PubMed ID: 17218855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin B(12) deficiency stimulates osteoclastogenesis via increased homocysteine and methylmalonic acid.
    Vaes BL; Lute C; Blom HJ; Bravenboer N; de Vries TJ; Everts V; Dhonukshe-Rutten RA; Müller M; de Groot LC; Steegenga WT
    Calcif Tissue Int; 2009 May; 84(5):413-22. PubMed ID: 19363664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.